- Projects & figures
- News & Events
- Managing your project
- About ERC
There is a web of filaments – essentially long strands of gas – that connects all the galaxies in the universe. This is known as the Cosmic Web and, so far, astrophysicist had only a partial idea of what it may have looked like. Now, ERC funded astronomer Michele Fumagalli, and his collaborators from the University of Durham and the RIKEN Cluster for Pioneering Research in Japan, are able to show the stunning images of this common thread that runs through our stars.
About the size of a big cherry, the first-of-its-kind 3D printed heart has cells, blood vessels, ventricles and chambers. This feat is the work of Prof. Tal Dvir and his team at Tel Aviv University. They managed to engineer such miniature organs using cells and biological materials that are originated from human patients. Besides the remarkable technical achievement, this breakthrough could potentially be the answer to the shortage of organ donors in the future.
Water vapour has been detected in the atmosphere of a remote planet with habitable temperatures. Two ERC grantees at the University College London (UCL) were among the coauthors of study.
On a clear summer night, look up to the sky and what do you see? Ordinary matter such as planets, stars maybe even an asteroid. Millions of little specks, as far as the eyes can reach. This ordinary matter, also known as baryonic matter, is the primary observable component of our universe. But is what we see all that is out there?
Diseases affecting the retina cause one quarter of worldwide blindness. To date, there are no treatments to restore lost retinal cells and visual function, making it urgent to find new therapeutic approaches. Can stem cells be the solution? Prof. Majlinda Lako aims at growing artificial replicas of the human retina using stem cells.
Key nutrients can improve vision both in ageing and in healthy eyes, according to EU-funded research. Doctors are now prescribing supplements of these nutrients, while the researchers are investigating other possible health benefits.
An EU-funded project is exploring what keeps people committed to a task even when they get bored, distracted or are tempted to stop. The findings could foster productivity-boosting strategies, improve robot-human interactions and even help treat borderline personality disorder.
At the forefront of medicine, gene therapy is based on the insertion of genes into an individual's cells and tissues to treat a disease. Scientists are currently testing several approaches to this experimental technique. One of them, Prof. Seppo Ylä-Herttuala, intends to develop a novel method to treat myocardial ischemia by activating endogenous genes to propel angiogenesis. If successful, he will open a new era in gene therapy.
More than 100 million people worldwide suffer from valvular heart disease, affecting one or more of the heart’s four valves and causing breathlessness, chest pain, dizziness and fainting. If severe valvular heart disease is not properly treated, chances of surviving decrease, especially in the elderly. The only effective therapy is heart valve replacement, which may entail some risks and lead to revision surgeries. What can be done to improve safety and durability of artificial heart valves?
Cell transplantation is a promising new approach for organ regeneration in disease or after injury. To support the differentiation of hepatocytes from stem cells, European researchers developed ex vivo organoids which precisely mimic liver architecture.